Volume 4, Issue 3 (Autumn 2000)                   2000, 4(3): 3-7 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aminbidokhti M, Rashidipour A, Ghorbani R, Hemati A. Comparison of the efficiency of conventional white light and blue light in neonatal Hyperbilirubinemia. Journal of Inflammatory Diseases. 2000; 4 (3) :3-7
URL: http://journal.qums.ac.ir/article-1-642-en.html
Abstract:   (11671 Views)
Abstract Background: Phototherapy seems to be the most useful therapy for jaundice. Objective: To compare the efficiency of conventional white light (Day light) and blue light in lowering of high blood level of bilirubin in neonates with hyperbilirubinemia. Methods: Neonates suffering from jaundice, who were admitted in Amir Al-Momenin hospital of Semnan university from May to Sep. 1998 were randomly divided into two groups. Patients in group one were put under blue light and the other group under conventional white light. Blood sample (2cc) was taken before therapy and 12hr and 24hr after phototherapy. Total and direct bilirubin blood levels were measured using standard laboratory procedures. Findings: The data indicated that total and direct bilirubin blood levels at 12hr and 24hr after phototherapy was significantly lower than those of pretreatment levels (P<0.01). There was no significant difference between direct bilirubin levels at 12hr and 24hr posttreatment among groups, but total bilirubin levels of blue light treatment group was significantly more than white light treatment group (P<0.01). Conclusion: Both white light and blue light are effective in lowering the levels of bilirubin in neonates. Therefore, each light alone or a combination of both lights can be used for treatment of neonatal jaundice.
Full-Text [PDF 834 kb]   (2039 Downloads)    
Type of Study: Research | Subject: Pediatrics

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb